Literature DB >> 7512993

A novel exon in the cystic fibrosis transmembrane conductance regulator gene activated by the nonsense mutation E92X in airway epithelial cells of patients with cystic fibrosis.

K Will1, T Dörk, M Stuhrmann, T Meitinger, R Bertele-Harms, B Tümmler, J Schmidtke.   

Abstract

Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. We report on a novel nonsense mutation that leads to exon skipping and the activation of a cryptic exon. Screening of genomic DNA from 700 German patients with CF uncovered four cases with the nonsense mutation E92X, a G-->T transversion that creates a termination codon and affects the first base of exon 4 of the CFTR gene. Lymphocyte RNA of two CF patients heterozygous for E92X was found to contain the wild type sequence and a differentially spliced isoform lacking exon 4. In RNA derived from nasal epithelial cells of E92X patients, a third fragment of longer size was observed. Sequencing revealed the presence of E92X and an additional 183-bp fragment, inserted between exons 3 and 4. The 183-bp sequence was mapped to intron 3 of the CFTR gene. It is flanked by acceptor and donor splice sites. We conclude that the 183-bp fragment in intron 3 is a cryptic CFTR exon that can be activated in epithelial cells by the presence of the E92X mutation. E92X abolishes correctly spliced CFTR mRNA and leads to severe cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512993      PMCID: PMC294265          DOI: 10.1172/JCI117172

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  Effect of 5' splice site mutations on splicing of the preceding intron.

Authors:  M Talerico; S M Berget
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

2.  The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508).

Authors:  E Kerem; M Corey; B S Kerem; J Rommens; D Markiewicz; H Levison; L C Tsui; P Durie
Journal:  N Engl J Med       Date:  1990-11-29       Impact factor: 91.245

3.  The organization of 3' splice-site sequences in mammalian introns.

Authors:  R Reed
Journal:  Genes Dev       Date:  1989-12       Impact factor: 11.361

4.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.

Authors:  S H Cheng; R J Gregory; J Marshall; S Paul; D W Souza; G A White; C R O'Riordan; A E Smith
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

5.  Exon definition may facilitate splice site selection in RNAs with multiple exons.

Authors:  B L Robberson; G J Cote; S M Berget
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

6.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

Review 7.  On/off regulation of gene expression at the level of splicing.

Authors:  P M Bingham; T B Chou; I Mims; Z Zachar
Journal:  Trends Genet       Date:  1988-05       Impact factor: 11.639

8.  Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2.

Authors:  R J Gregory; D P Rich; S H Cheng; D W Souza; S Paul; P Manavalan; M P Anderson; M J Welsh; A E Smith
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

9.  Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance.

Authors:  N Kartner; J W Hanrahan; T J Jensen; A L Naismith; S Z Sun; C A Ackerley; E F Reyes; L C Tsui; J M Rommens; C E Bear
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

10.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

View more
  11 in total

1.  Two aberrant splicings caused by mutations in the insulin receptor gene in cultured lymphocytes from a patient with Rabson-Mendenhall's syndrome.

Authors:  Y Takahashi; H Kadowaki; A Ando; J D Quin; A C MacCuish; Y Yazaki; Y Akanuma; T Kadowaki
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

2.  Genomic analysis of human multigene families using chromosome-specific vectorette PCR.

Authors:  T P Moynihan; A F Markham; P A Robinson
Journal:  Nucleic Acids Res       Date:  1996-10-15       Impact factor: 16.971

Review 3.  Normal and abnormal mechanisms of gene splicing and relevance to inherited skin diseases.

Authors:  Vesarat Wessagowit; Vijay K Nalla; Peter K Rogan; John A McGrath
Journal:  J Dermatol Sci       Date:  2005-07-27       Impact factor: 4.563

4.  Detailed molecular characterization of a novel IDS exonic mutation associated with multiple pseudoexon activation.

Authors:  L Grodecká; T Kováčová; M Kramárek; S Seneca; K Stouffs; C De Laet; F Majer; T Kršjaková; P Hujová; K Hrnčířová; P Souček; W Lissens; E Buratti; Tomas Freiberger
Journal:  J Mol Med (Berl)       Date:  2016-11-12       Impact factor: 4.599

5.  Species- and tissue-specific expression of the C-terminal alternatively spliced form of the tumor suppressor p53.

Authors:  K Will; G Warnecke; S Bergmann; W Deppert
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

6.  Exon redefinition by a point mutation within exon 5 of the glucose-6-phosphatase gene is the major cause of glycogen storage disease type 1a in Japan.

Authors:  S Kajihara; S Matsuhashi; K Yamamoto; K Kido; K Tsuji; A Tanae; S Fujiyama; T Itoh; K Tanigawa; M Uchida
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

7.  A novel donor splice site in intron 11 of the CFTR gene, created by mutation 1811+1.6kbA-->G, produces a new exon: high frequency in Spanish cystic fibrosis chromosomes and association with severe phenotype.

Authors:  M Chillón; T Dörk; T Casals; J Giménez; N Fonknechten; K Will; D Ramos; V Nunes; X Estivill
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

8.  Independent origins of cystic fibrosis mutations R334W, R347P, R1162X, and 3849 + 10kbC-->T provide evidence of mutation recurrence in the CFTR gene.

Authors:  N Morral; R Llevadot; T Casals; P Gasparini; M Macek; T Dörk; X Estivill
Journal:  Am J Hum Genet       Date:  1994-11       Impact factor: 11.025

9.  Detection of more than 50 different CFTR mutations in a large group of German cystic fibrosis patients.

Authors:  T Dörk; F Mekus; K Schmidt; J Bosshammer; R Fislage; T Heuer; V Dziadek; T Neumann; N Kälin; U Wulbrand
Journal:  Hum Genet       Date:  1994-11       Impact factor: 4.132

Review 10.  Defective splicing, disease and therapy: searching for master checkpoints in exon definition.

Authors:  Emanuele Buratti; Marco Baralle; Francisco E Baralle
Journal:  Nucleic Acids Res       Date:  2006-07-19       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.